TGFB2 and cancer: On the contrary, SMARCA4 interacts with TGFB2-AS1 long non-coding RNA in breast cancer, resulting in transcriptional repression of TGFB2 and SOX2, and therefore, leading to attenuation of TGF-β signaling and loss of cancer stem cell-like characteristics [125].